JT
CTNM

Jupiter Topco’s Contineum Therapeutics CTNM Stock Holding History

Jupiter Topco’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.8M Buy
+2,734,836
New +$35.9M 0.02% 457

Other funds holding CTNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco's CTNM Position: Q2 2026 in Review

Jupiter Topco opened a new position in Contineum Therapeutics (CTNM) in Q2 2026: 2,734,836 shares worth $44.8M. The stake represents 0.02% of the portfolio and ranks #457 among its holdings.

91 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

  • Jupiter Topco held 2,734,836 shares of Contineum Therapeutics worth $44.8M as of Q2 2026.
  • Contineum Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Contineum Therapeutics made up 0.02% of Jupiter Topco's portfolio in Q2 2026, its #457 holding.
  • 91 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.